Skip to content

Effects of Exercise on Functional Dyspepsia Based on Rome IV

Effects of Exercise on Patients With Functional Dyspepsia Based on Rome IV Criteria

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04540549
Enrollment
260
Registered
2020-09-07
Start date
2020-09-01
Completion date
2021-08-31
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Keywords

functional dyspepsia, exercise, Rome IV

Brief summary

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent gastroduodenal symptoms in the absence of any organic or metabolic disease that is likely to explain the symptoms. Functional dyspepsia has a high incidence in the population. A recent research showed that FD is present in 11% of the Italian general population. It dramatically reduces a patient's quality of life, with an economic impact due to frequent clinical consultations, medication, and time off work. Although some experts recommend exercise as a first-line treatment for functional dyspepsia, there is little data on the relationship between exercise and functional dyspepsia, which needs to be confirmed by further research. Investigators designed this randomized controlled study to assess the effect of exercise on patients with functional dyspepsia based on Rome IV criteria.

Detailed description

Functional dyspepsia is one of the most common gastrointestinal disorders (FGIDs) encountered in clinical practice. Functional dyspepsia is a clinical syndrome characterized by chronic and recurrent gastroduodenal symptoms in the absence of any organic or metabolic disease that is likely to explain the symptoms. Functional dyspepsia has a high incidence in the population. A recent research showed that FD is present in 11% of the Italian general population. It dramatically reduces a patient's quality of life, with an economic impact due to frequent clinical consultations, medication, and time off work. Regular physical activity and exercise may be a way of life to reduce low levels of inflammation throughout the body, thereby reducing the risk of developing chronic diseases. Multiple studies have shown that after regular exercise, markers of inflammation and oxidative stress are reduced, while markers of inflammation and antioxidants are increased, reflecting the anti-inflammatory and antioxidant properties of exercise. Rome IV was introduced in 2016. Rome IV introduced more precisely define the minimal thresholds for frequency and severity of each individual symptom, primarily for scientific purposes, but data still need to be collected to define thresholds based on the frequency and/or severity of symptoms that impair quality of life. Although some experts recommend exercise as a first-line treatment for functional dyspepsia, there is little data on the relationship between exercise and functional dyspepsia, which needs to be confirmed by further research. Investigators designed this randomized controlled study to assess the effect of exercise on patients with functional dyspepsia based on Rome IV criteria.

Interventions

BEHAVIORALexercise

Jogging or cycling ≥5 days/week, 30-60 min/d

Sponsors

Second Affiliated Hospital of Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥18 years old 2. Functional dyspepsia meeting Rome IV criteria 3. Gastroscope, blood routine, liver function and Hp examination were performed within the last year, and the results were normal 4. No prokinetic drug, proton pump inhibitor or mucosal protective agent was used in the last two weeks 5. Sign informed consent and be willing to participate in this study

Exclusion criteria

1. There are organic diseases that may explain the symptoms, such as peptic ulcer, gastrointestinal neoplasms, history of hepatobiliary and pancreatic diseases, history of tumor diseases, and history of metabolic diseases 2. Pregnancy, prepregnancy, or lactation 3. History of abdominal surgery 4. Mental illness 5. Severe impairment of heart, liver, or kidney function or respiratory function 6. Recent use of antidepressant, hormone, NSAIDs 7. The main symptoms are gastroesophageal reflux disease or irritable bowel syndrome 8. Failure to increase exercise levels

Design outcomes

Primary

MeasureTime frameDescription
Weekly global symptom assessment12 weeksPatients are asked to answer the following yes/no question once a week: In the past 7 days, have you had adequate relief of your stomach symptoms?

Secondary

MeasureTime frameDescription
Eight items of dyspepsia symptom score questionnaire(epigastric pain, epigastric burning, postprandial fullness, early satiety, belching, bloating, nausea, and vomiting)12 weeksseverity(0=absent; 1=mild; 2=moderate); frequency (1 = less than once per week; 2 = once per week; 3 = two to three times per week; 4 = four to five times per week; 5 = daily) 3=severe and interfering with daily activities

Countries

China

Contacts

Primary ContactJinhai Wang, MD
jinhaiwang@hotmail.com+86-29-87679335
Backup ContactZhongcao Wei, MD
1977816504@qq.com+86-29-18700932477

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026